MAIA Biotechnology, Inc. (MAIA) Press Releases https://ir.maiabiotech.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/maiabiotech/files/theme/images/logo-sm.png MAIA Biotechnology, Inc. Logo Equisolve Investor Relations Suite <![CDATA[MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University]]> https://ir.maiabiotech.com/news-events/press-releases/detail/179/maia-biotechnology-opens-enrollment-for-phase-2-expansion Thu, 18 Jun 26 08:30:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/179/maia-biotechnology-opens-enrollment-for-phase-2-expansion <![CDATA[MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial]]> https://ir.maiabiotech.com/news-events/press-releases/detail/178/maia-biotechnology-activates-and-opens-enrollment-at-second Wed, 10 Jun 26 09:15:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/178/maia-biotechnology-activates-and-opens-enrollment-at-second <![CDATA[MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial]]> https://ir.maiabiotech.com/news-events/press-releases/detail/177/maia-biotechnology-reports-strong-enrollment-and-dosing Thu, 04 Jun 26 09:45:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/177/maia-biotechnology-reports-strong-enrollment-and-dosing <![CDATA[MAIA Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 THIO-101 Trial Expansion]]> https://ir.maiabiotech.com/news-events/press-releases/detail/176/maia-biotechnology-receives-fda-clearance-to-open-u-s Wed, 03 Jun 26 09:45:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/176/maia-biotechnology-receives-fda-clearance-to-open-u-s <![CDATA[MAIA Biotechnology Announces Open Market Purchases by CEO and Director]]> https://ir.maiabiotech.com/news-events/press-releases/detail/175/maia-biotechnology-announces-open-market-purchases-by-ceo Tue, 02 Jun 26 09:45:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/175/maia-biotechnology-announces-open-market-purchases-by-ceo <![CDATA[MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology]]> https://ir.maiabiotech.com/news-events/press-releases/detail/174/maia-biotechnology-presents-trial-in-progress-poster-for Mon, 01 Jun 26 08:00:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/174/maia-biotechnology-presents-trial-in-progress-poster-for <![CDATA[MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer]]> https://ir.maiabiotech.com/news-events/press-releases/detail/173/maia-biotechnology-activates-first-u-s-site-for-ongoing Thu, 16 Apr 26 09:20:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/173/maia-biotechnology-activates-first-u-s-site-for-ongoing <![CDATA[MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy]]> https://ir.maiabiotech.com/news-events/press-releases/detail/172/maia-biotechnology-expects-recent-33-million-capital-raise Wed, 08 Apr 26 09:00:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/172/maia-biotechnology-expects-recent-33-million-capital-raise <![CDATA[MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer]]> https://ir.maiabiotech.com/news-events/press-releases/detail/171/maia-biotechnology-reports-overall-survival-exceeding-two Tue, 31 Mar 26 09:15:00 -0400 https://ir.maiabiotech.com/news-events/press-releases/detail/171/maia-biotechnology-reports-overall-survival-exceeding-two <![CDATA[MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock]]> https://ir.maiabiotech.com/news-events/press-releases/detail/170/maia-biotechnology-announces-closing-of-30-million Wed, 04 Mar 26 16:00:00 -0500 https://ir.maiabiotech.com/news-events/press-releases/detail/170/maia-biotechnology-announces-closing-of-30-million